[KongchangAI]
Unverified93% confidenceDecision RuleTime unknown

若需要全天候控制过敏症状且不影响日常活动,应优先选择第二代抗组胺药(如氯雷他定、西替利嗪),而非扑尔敏

1
Sources
93%
Confidence
Long-term
Relevance
-
First Seen

Sources

Related Entities

Related Claims

Cite This Claim

Stable URI
https://kongchang.com/claim/791730
API
curl https://kongchang.com/api/v1/knowledge/claims/791730
MCP
get_claim(id=791730)